PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Veterinary Sciences, University of Messina, Messina, Italy.\', \'Center for Advanced Studies and Technology, G. d\'Annunzio University, Chieti, Italy.\', \'YDA - Institute for Clinical Immunotherapy and Advanced Biological Treatments, Pescara, Italy.\', \'National Research Council of Italy (IFC-CNR), Clinical Physiology Institute, Pisa, Italy.\', \'Department of Clinical and Experimental Medicine, Unit and School of Allergy and Clinical Immunology, University of Messina, Messina.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/07853890.2021.1921252
?:hasPublicationType
?:journal
  • Annals of medicine
is ?:pmid of
?:pmid
?:pmid
  • 34042528
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.481
?:rankingScore_hIndex
  • 103
is ?:relation_isRelatedTo_publication of
?:title
  • Alarmins, COVID-19 and comorbidities.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all